While APOE4 cerebral organoids demonstrate p-tau and Aβ at 12 weeks, protocols similar to COs observe p-tau and Aβ only at 180 DIV, suggesting that excitatory/inhibitory neuron interactions may facilitate AD pathology (Lin et al., 2018; Zhao et al., 2020). The gene discussed is MAPT; the disease is Alzheimer disease.